Vertex Pharma

VRTX

----

Current ValuationThe current P/E ratio is 29.09, within the reasonable range, cheaper than 59.16% of the time in the past 1 years, and the industry ranks 45/602, the industry Median -2.07.

29.09xP/E

Stock price$505.64Earnings per share$17.38

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

020406080

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
AMGNUSAmgen	25.54x	11.27%	$223.32B
VRTXUSVertex Pharma	29.09x	36.48%	$128.16B
REGNUSRegeneron Pharma	17.65x	7.98%	$76.40B
UTHRUSUnited Therap	17.83x	6.05%	$23.38B
GMABUSGenmab A/S	28.60x	26.27%	$22.54B
ASNDUSAscendis Pharmac	17.45x	470.27%	$15.03B
NBIXUSNeurocrine Biosciences	20.67x	50.69%	$14.58B
EXELUSExelixis	16.83x	16.33%	$14.48B
TGTXUSTG Therap	18.36x	64.86%	$8.11B
CDNAUSCaredex	29.38x	618.00%	$3.26B
PBYIUSPuma BioTech	18.95x	37.70%	$506.39M
KMDAUSKamada	20.46x	36.43%	$455.33M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.